Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesInhibition of Chemokine Receptor Expression on Uveal Melanomas by CXCR4 siRNA Blocks Tumor Cell Invasion and Liver Metastasis of Uveal Melanoma Cells
Investigative Ophthalmology and Visual Science, 06/25/09
Li H et al. - CXCR4 is a key chemokine receptor that may account for the organ-specific homing of human uveal melanomas to the liver, which contains significant quantities of CXCL2, the only known ligand for CXCR4. CXCR4 is a potential therapeutic target for preventing the initial establishment of liver metastases, but has limited application for use in advanced liver tumors.
Today in Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Patients' preferences for positioning during phaco-emulsification under topical-intracameral anaesthesia
Clinical and Experimental Ophthalmology, 10/13/09
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Sponsor
Article Search
Sponsor
Sponsor